The Goldman Sachs technology M&A team, led by Sam Britton, has cashed in on its software focus and decades of experience to dominate 2019's biggest deals.Technologyread more
American small and medium-size companies that rely on China are scrambling to adjust their business plans in response to the escalating trade war.Traderead more
Here are the products that stand to be the most affected by China's new tariffs on $75 billion worth of U.S. goods.Marketsread more
The summit comes amid fears over a global economic slowdown, and U.S. tensions over trade allies, Iran and Russia.Politicsread more
The world's second biggest economy is past a point where it cannot ignore its enormous debt anymore, according to an analyst.China Economyread more
Carl Medlock used to work at Tesla. Now he's one of the few people in the U.S. that can fix the company's original Roadster electric vehicles.Technologyread more
Trump does have some powerful tools that would not require approval from U.S. Congress.Politicsread more
Stocks dropped after Donald Trump ordered that U.S. manufacturers find alternatives to their operations in China.US Marketsread more
As demand for lab monkeys continues to rise, U.S. scientists are reporting delays in research projects because they can't obtain enough animals, according to the National...Politicsread more
The European Union will respond in kind if the U.S. imposes tariffs on France over digital tax plan, EU chief Donald Tusk told G-7.Technologyread more
Trump said he will raise tariffs on $250 billion in Chinese goods to 30% and hike duties on another $300 billion in products to 15%.Politicsread more
Canadian marijuana producer Canopy Growth has a chance to make billions in America if the crop becomes legal federally, CEO Bruce Linton told CNBC.
"On a global basis, you'll see THC is an active ingredient in probably 85 - 90 percent of our total global revenues" not including the U.S., he said Thursday on "Fast Money." If tetrahydrocannabinol (THC) is legalized in the U.S., "it's a many tens of billion dollar opportunity and it's going to be coming down to great products with great brands."
Canopy wants to introduce THC products to the U.S. market that could compete with alcohol and opioids, but only a non-psychoactive cannabis compound known as cannabidiol (CBD) has been authorized by the federal government. The 2018 Farm Bill legalized the manufacturing, distribution and selling of hemp-derived CBD.
While pot companies wait on the sidelines as more and more states legalize marijuana within their own boundaries, Linton said clearing CBD is a "great first step" because CBD research can yield results helpful for THC. The federal Food and Drug Administration will be "very active and useful" in providing perspective on many claims about the chemical.
"It's a big deal ... [because] we can actually operate with a federally controlled program, which means we don't jeopardize say working with Bank of America, all the things that we've been able to enjoy by being on the New York Stock Exchange," Linton said.
Shares of Canopy are up 94 percent this year, recovering from losses in November.